Atomistry » Potassium » PDB 2o8l-2qxl » 2qki
Atomistry »
  Potassium »
    PDB 2o8l-2qxl »
      2qki »

Potassium in PDB 2qki: Human C3C in Complex with the Inhibitor Compstatin

Protein crystallography data

The structure of Human C3C in Complex with the Inhibitor Compstatin, PDB code: 2qki was solved by B.J.C.Janssen, E.F.Halff, J.D.Lambris, P.Gros, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 33.00 / 2.40
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 85.809, 124.754, 127.367, 90.00, 95.08, 90.00
R / Rfree (%) 21.3 / 28.1

Other elements in 2qki:

The structure of Human C3C in Complex with the Inhibitor Compstatin also contains other interesting chemical elements:

Bromine (Br) 32 atoms

Potassium Binding Sites:

The binding sites of Potassium atom in the Human C3C in Complex with the Inhibitor Compstatin (pdb code 2qki). This binding sites where shown within 5.0 Angstroms radius around Potassium atom.
In total 5 binding sites of Potassium where determined in the Human C3C in Complex with the Inhibitor Compstatin, PDB code: 2qki:
Jump to Potassium binding site number: 1; 2; 3; 4; 5;

Potassium binding site 1 out of 5 in 2qki

Go back to Potassium Binding Sites List in 2qki
Potassium binding site 1 out of 5 in the Human C3C in Complex with the Inhibitor Compstatin


Mono view


Stereo pair view

A full contact list of Potassium with other atoms in the K binding site number 1 of Human C3C in Complex with the Inhibitor Compstatin within 5.0Å range:
probe atom residue distance (Å) B Occ
A:K3002

b:57.8
occ:1.00
O A:VAL533 2.6 42.0 1.0
O A:PRO505 2.8 35.2 1.0
OD1 A:ASP535 2.9 47.5 1.0
OD1 A:ASP532 3.0 46.0 1.0
OD2 A:ASP532 3.3 44.6 1.0
CG A:ASP532 3.4 43.3 1.0
CG A:ASP535 3.6 46.8 1.0
C A:PRO505 3.8 35.2 1.0
C A:VAL533 3.8 42.0 1.0
O A:HOH3106 3.8 51.4 1.0
OD2 A:ASP535 4.1 47.8 1.0
CA A:PRO505 4.1 35.4 1.0
N A:VAL533 4.1 40.7 1.0
N A:ASP535 4.2 45.0 1.0
CA A:VAL533 4.6 41.1 1.0
C A:LYS534 4.6 44.5 1.0
CB A:ASP535 4.7 46.1 1.0
N A:LYS534 4.7 42.6 1.0
CA A:LYS534 4.7 43.9 1.0
CA A:ASP535 4.8 45.8 1.0
CB A:ASP532 4.8 40.9 1.0
CB A:PRO505 4.9 35.1 1.0
N A:SER506 5.0 35.0 1.0

Potassium binding site 2 out of 5 in 2qki

Go back to Potassium Binding Sites List in 2qki
Potassium binding site 2 out of 5 in the Human C3C in Complex with the Inhibitor Compstatin


Mono view


Stereo pair view

A full contact list of Potassium with other atoms in the K binding site number 2 of Human C3C in Complex with the Inhibitor Compstatin within 5.0Å range:
probe atom residue distance (Å) B Occ
C:K602

b:64.3
occ:1.00
O C:HOH522 2.7 76.3 1.0
O C:ARG1405 2.8 47.5 1.0
O C:GLY1402 2.9 49.4 1.0
O C:ALA1400 2.9 47.4 1.0
C C:GLY1402 3.8 49.4 1.0
C C:ARG1405 4.0 47.7 1.0
C C:ALA1400 4.1 47.3 1.0
N C:ARG1405 4.3 48.8 1.0
C C:ASN1401 4.3 48.3 1.0
N C:GLY1402 4.4 48.7 1.0
CA C:ASN1401 4.4 48.1 1.0
CA C:VAL1403 4.4 49.9 1.0
N C:VAL1403 4.5 49.7 1.0
N C:ASP1404 4.5 49.7 1.0
O C:ASN1401 4.7 48.3 1.0
CA C:ARG1405 4.7 48.3 1.0
N C:ASN1401 4.8 47.8 1.0
C C:VAL1403 4.8 49.9 1.0
CA C:GLY1402 4.8 49.1 1.0

Potassium binding site 3 out of 5 in 2qki

Go back to Potassium Binding Sites List in 2qki
Potassium binding site 3 out of 5 in the Human C3C in Complex with the Inhibitor Compstatin


Mono view


Stereo pair view

A full contact list of Potassium with other atoms in the K binding site number 3 of Human C3C in Complex with the Inhibitor Compstatin within 5.0Å range:
probe atom residue distance (Å) B Occ
D:K3002

b:41.6
occ:1.00
O D:VAL533 2.6 48.9 1.0
O D:PRO505 2.6 41.6 1.0
OD1 D:ASP535 2.7 54.0 1.0
OD1 D:ASP532 2.7 47.8 1.0
O D:HOH3171 3.1 37.4 1.0
C D:VAL533 3.7 48.4 1.0
C D:PRO505 3.7 41.7 1.0
CG D:ASP535 3.8 52.4 1.0
CG D:ASP532 3.8 48.1 1.0
N D:ASP535 3.9 50.9 1.0
N D:VAL533 4.1 47.1 1.0
CA D:PRO505 4.3 41.8 1.0
OD2 D:ASP532 4.3 50.4 1.0
C D:LYS534 4.3 50.7 1.0
CA D:ASP535 4.4 50.7 1.0
CB D:ASP535 4.5 51.1 1.0
CA D:VAL533 4.5 47.6 1.0
OE2 D:GLU599 4.5 54.7 1.0
N D:LYS534 4.6 49.6 1.0
CA D:LYS534 4.6 50.4 1.0
OD2 D:ASP535 4.7 54.8 1.0
CB D:PRO505 4.8 41.4 1.0
N D:SER506 4.8 42.0 1.0
O D:LYS534 4.9 51.1 1.0
C D:ASP532 5.0 46.4 1.0

Potassium binding site 4 out of 5 in 2qki

Go back to Potassium Binding Sites List in 2qki
Potassium binding site 4 out of 5 in the Human C3C in Complex with the Inhibitor Compstatin


Mono view


Stereo pair view

A full contact list of Potassium with other atoms in the K binding site number 4 of Human C3C in Complex with the Inhibitor Compstatin within 5.0Å range:
probe atom residue distance (Å) B Occ
D:K3003

b:80.5
occ:1.00
NH2 D:ARG13 2.8 44.2 1.0
O D:ALA601 2.8 43.1 1.0
C D:ALA601 3.4 43.6 1.0
O D:LYS475 3.5 41.0 1.0
C D:LYS475 3.7 41.4 1.0
CZ D:ARG13 3.7 46.1 1.0
NH1 D:ARG13 3.8 47.4 1.0
CB D:ALA601 3.9 42.8 1.0
N D:ASP602 4.0 44.3 1.0
CA D:ASP602 4.1 45.2 1.0
N D:GLY476 4.1 41.7 1.0
OH D:TYR107 4.1 44.9 1.0
CA D:GLY476 4.2 42.2 1.0
CA D:ALA601 4.3 43.4 1.0
CA D:LYS475 4.3 41.1 1.0
O D:VAL598 4.4 42.3 1.0
N D:ILE603 4.6 44.8 1.0
C D:ASP602 4.7 45.1 1.0
CG2 D:ILE603 4.8 43.4 1.0
BR D:BR703 4.8 54.0 0.8
CB D:HIS132 4.9 44.0 1.0
NE D:ARG13 5.0 46.3 1.0

Potassium binding site 5 out of 5 in 2qki

Go back to Potassium Binding Sites List in 2qki
Potassium binding site 5 out of 5 in the Human C3C in Complex with the Inhibitor Compstatin


Mono view


Stereo pair view

A full contact list of Potassium with other atoms in the K binding site number 5 of Human C3C in Complex with the Inhibitor Compstatin within 5.0Å range:
probe atom residue distance (Å) B Occ
F:K605

b:51.1
occ:1.00
O F:ARG1405 2.7 39.6 1.0
O F:GLY1402 2.8 43.6 1.0
O F:ALA1400 2.9 44.7 1.0
C F:ARG1405 3.8 40.1 1.0
C F:GLY1402 3.9 43.5 1.0
O F:ASN1401 4.0 43.6 1.0
C F:ALA1400 4.1 44.3 1.0
C F:ASN1401 4.1 43.8 1.0
O F:VAL1403 4.3 43.2 1.0
N F:ARG1405 4.4 41.4 1.0
CA F:ASN1401 4.5 44.1 1.0
N F:GLY1402 4.5 43.6 1.0
C F:VAL1403 4.6 43.0 1.0
CA F:ARG1405 4.6 40.8 1.0
CA F:VAL1403 4.7 43.1 1.0
N F:ASN1401 4.7 44.2 1.0
N F:VAL1403 4.8 43.4 1.0
N F:TYR1406 4.8 39.8 1.0
CA F:GLY1402 4.8 43.7 1.0
CA F:TYR1406 4.9 38.9 1.0

Reference:

B.J.Janssen, E.F.Halff, J.D.Lambris, P.Gros. Structure of Compstatin in Complex with Complement Component C3C Reveals A New Mechanism of Complement Inhibition. J.Biol.Chem. V. 282 29241 2007.
ISSN: ISSN 0021-9258
PubMed: 17684013
DOI: 10.1074/JBC.M704587200
Page generated: Mon Aug 12 06:54:45 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy